Deep brain stimulation for the treatment of atypical parkinsonism

Movement Disorders

Volumn 22, Issue 15, 2007, Pages 2149-2155

  Shih, Ludy C ^a   Tarsy, Daniel ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Atypical parkinsonism; Deep brain stimulation; Hypoxic ischemic parkinsonism; Multiple system atrophy; Radiation induced parkinsonism

Indexed keywords

LEVODOPA; PERGOLIDE;

BRADYKINESIA; BRAIN DEPTH STIMULATION; DELIRIUM; DRUG DOSE REDUCTION; DYSARTHRIA; DYSKINESIA; DYSPHAGIA; FEVER; GAIT DISORDER; HUMAN; HYPOMANIA; LETHARGY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; PARANOIA; PARKINSONISM; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHY DRAGER SYNDROME; TREATMENT RESPONSE;

DEEP BRAIN STIMULATION; HUMANS; PARKINSONIAN DISORDERS;

EID: 38049018084     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21648     Document Type: Review

References (49)

1. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
2. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554-560.
3. Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990.
4. Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459-467.
5. Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord 2005;20:523-539.
6. Hallett M, Litvan I. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Task force on surgery for Parkinson's disease of the American Academy of Neurology therapeutic and technology assessment committee. Mov Disord 2000;15:436-438.
7. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21 Suppl 14:S290-S304.
8. Tarsy D. Diagnostic criteria for parkinson's disease. In: Ebadi M, Pfeiffer R, editors. Parkinson's disease. Boca Raton: CRC Press; 2005. p 569-578.
9. Litvan I. Parkinsonian features: when are they Parkinson disease? JAMA 1998;280:1654-1655.
10. Hughes A, Ben-Shlomo Y, Daniel S, Lees A. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;57:S34-S38.
11. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
13. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;68:434-440.
14. Lang AE, Lozano A, Montgomery EB, Tasker RR, Hutchison WD. Posteroventral medial pallidotomy in advanced Parkinson's disease. Adv Neurol 1999;80:575-583.
15. Goto S, Kunitoku N, Soyama N, et al. Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy. Neurology 1997;49:707-710.
16. Krauss JK, Jankovic J, Lai EC, Rettig GM, Grossman RG. Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism. Arch Neurol 1997;54:1026-1029.
17. Speelman JD, Schuurman R, de Bie R, Esselink R, Bosch D. Stereotactic neurosurgery for tremor. Mov Disord 2002;17:S84-S88.
18. Berciano J, Valldeoriola F, Ferrer I, et al. Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov Disord 2002;17:812-816.
19. Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003;61:247-249.
20. Lezcano E, Gomez-Esteban JC, Zarranz JJ, et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 2004;19:973-977.
21. Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy-parkinsonism. Report of four cases. J Neurosurg 2003;98:882-887.
22. Alterman R, Tagliati M, Shils J, Rogers J. Subthalamic nucleus deep brain stimulation in two cases of multiple system atrophy. Mov Disord 2005;20:S129.
23. Chou KL, Forman MS, Trojanowski JQ, Hurtig HI, Baltuch GH. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. J Neurosurg 2004;100:553-556.
24. Talmant V, Esposito P, Stilhart B, Mohr M, Tranchant C. [Subthalamic stimulation in a patient with multiple system atrophy: a clinicopathological report]. Rev Neurol (Paris) 2006;162:363-370.
25. Huang Y, Garrick R, Cook R, O'Sullivan D, Morris J, Halliday GM. Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy. Mov Disord 2005;20: 1042-1047.
26. Patrick S, Kristl V, Miet DL, et al. Deep brain stimulation of the internal pallidum in multiple system atrophy. Parkinsonism Relat Disord 2006;12:181-183.
27. Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005;62:1250-1255.
28. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
29. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-845.
30. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg 1998;89:713-718.
31. Schupbach MW, Welter ML, Bonnet AM, et al. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Mov Disord 2007;22:257-261.
32. Pinter MM, Alesch F, Murg M, Helscher RJ, Binder H. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol 1999;246:907-913.
33. Wenning GK, Seppi K, Tison F, Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 2002;109:307-320.
34. Krack P, Dowsey PL, Benabid AL, et al. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism. Neurology 2000;54:2182-2184.
35. Revilla F, Mink J, McGee-Minnich L, et al. Radiation-induced parkinsonism with good response to levodopa and bilateral subthalamic nuclei stimulation. Mov Disord 2002;17:1113.
36. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
37. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003;99:489-495.
38. Eidelberg D, Takikawa S, Moeller JR, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993;33:518-527.
39. Antonini A, Leenders KL, Vontobel P, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997;120:2187-2195.
40. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002;73:517-523.
41. Kim YJ, Ichise M, Ballinger JR, et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP Mov Disord 2002;17:303-312.
42. Lantos PL. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 1998;57:1099-1111.
43. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166.
44. Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-1842.
45. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004;3:309-316.
46. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123 (Part 9):1767-1783.
47. Mazzone P, Lozano A, Stanzione P, et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005;16:1877-1881.
48. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 2005;16: 1883-1887.
49. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130 (Part 6):1596-1607.